UPDATE - Canaccord Genuity Downgraded XOMA, Ltd. (XOMA) to Hold; Waiting on Sidelines for 052 Phase 2 Diabetes Data in H1/11
Tweet Send to a Friend
UPDATE - Canaccord Genuity downgraded XOMA, Ltd. (NASDAQ: XOMA) from Buy to Hold. PT increased to $5.
Canaccord analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
